AZD1386 Japanese Multiple Ascending Dosing Study

NCT00736658 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Pain

Interventions

DRUG: AZD1386
DRUG: Placebo

Sponsor

AstraZeneca